Showing 2501-2510 of 5618 results for "".
- Long-term Renal Implications of Severe COVID-19: A Call to Action for Nephrologistshttps://reachmd.com/news/long-term-renal-implications-of-severe-covid-19-a-call-to-action-for-nephrologists/2475270/Understanding the often unseen, lasting impacts of severe COVID-19 on key organ systems, particularly the kidneys, has become a pressing concern for nephrologists and internal medicine specialists. Many survivors navigate a spectrum of
- Insurance Churn Linked to Worse Diabetes Control in Community Health Center Patientshttps://reachmd.com/news/insurance-churn-linked-to-worse-diabetes-control-in-community-health-center-patients/2486335/Insurance churn—defined as losing coverage for multiple medical visits—was associated with near-term worsening in diabetes measures among low-income adults receivin
- The Overlooked Impact of Paternal Mental Health on Child Developmenthttps://reachmd.com/news/the-overlooked-impact-of-paternal-mental-health-on-child-development/2475195/Despite the routine focus on maternal wellbeing during pediatric visits, emerging data reveal that paternal mental health is associated with children’s cogniti
- Risk of Long COVID Declined Over Course of Pandemichttps://reachmd.com/news/risk-of-long-covid-declined-over-course-of-pandemic/2467428/Visit the News Hub Risk of long COVID declined over course of pandemicDrop attributed mostly to vaccination but remaining risk still significantSARA MOSERThe risk of lon
- Psilocybin Generates Psychedelic Experience by Disrupting Brain Networkhttps://reachmd.com/news/psilocybin-generates-psychedelic-experience-by-disrupting-brain-network/2467438/Visit the News Hub Psilocybin generates psychedelic experience by disrupting brain networkStudy advances efforts to harness drug's mind-altering power to treat mental illnessSara
- Sleep Disorders in Childhood Increase the Risk of Developing Symptoms of Attention Deficit Disorder and Hyperactivityhttps://reachmd.com/news/sleep-disorders-in-childhood-increase-the-risk-of-developing-symptoms-of-attention-deficit-disorder-and-hyperactivity/2467074/An investigation by CIBER led by Llúcia González-Safont, a researcher in the area of Epidemiology and Public Health (CIBERESP) from the Faculty of Nursing and Podiatry at the University of Valencia and visiting lecturer at the
- Compromised Breaths: The Legacy of Passive Smoking in Pediatric Healthhttps://reachmd.com/news/compromised-breaths-the-legacy-of-passive-smoking-in-pediatric-health/2483219/Secondhand smoke (SHS) poses lasting risks for children, with emerging research suggesting possible intergenerational associations linked to paternal exposures. This ex
- Personalized Neoantigen Vaccine and Pembrolizumab in Advanced Hepatocellular Carcinoma: A Phase 1/2 Trialhttps://reachmd.com/news/personalized-neoantigen-vaccine-and-pembrolizumab-in-advanced-hepatocellular-carcinoma-a-phase-12-trial/2467329/Safety, feasibility and clinical responsesThe baseline demographic and clinical characteristics of the study population are shown in Table 1. The first and last patients were enrolled on June 1
- Study Shows Prognostic Value of 40-GEP in Advanced cSCChttps://reachmd.com/news/study-shows-prognostic-value-of-40-gep-in-advanced-cscc/2474383/A new multi-institutional study indicates that a 40-gene expression profile (40-GEP) test with traditional staging enhances risk stratification for cutaneous squamous cell carcinoma (cSCC), even among patients already categorized as high- or very-high-risk using Na
- Intranasal Foralumab Receives Fast Track Designation as Potential Tx for Non-Active SPMShttps://reachmd.com/news/intranasal-foralumab-receives-fast-track-designation-as-potential-tx-for-non-active-spms/2467753/An intranasal formulation for foralumab (Tiziana Life Sciences, New York, NY) has been granted Fast Track Designation by the Food and Drug Administration (FDA) for investigation as a potential treatment for non-active Secondary Progressive Multiple Sclerosis (na-SPMS). Foralumab is